This study aimed to characterize the epidemiological profile of patients with HIV/AIDS at an outpatient service, to analyze the infection stage on the patient's first return, lethality and program evasion. A descriptive and analytical epidemiological study was carried out during nursing appointments with 1837 clients. Most participants were men (1.71 men/1 woman), between 30 and 39 years old (46.8%); residents in São Paulo (86.5%); low education level (76.3%). Most women were living with partners (45.4%), whereas most men were single (53.3%). The main category of exposure was heterosexual behavior (83.5% among men and 71.2% among women). Both male and female participations discovered their HIV/AIDS positive condition in advanced stages (57%). Opportunistic infection levels were significantly higher (p < 0.05) among men. For men and women, the predominant opportunistic infection was tuberculosis (26.2%). CD4 < 350 results on the first return were significantly higher (p = 0.04) among women. Death risk was greater among women (OR = 1.72), whereas the risk of treatment evasion was greater among men (OR = 1.72).
O objetivo deste trabalho foi criar instrumentos para o levantamento e tratamento estatístico de informações de interesse epidemiológico e de evolução clínica dos pacientes "HIV" positivos atendidos pelo "Centro de Controle de Deficiências Imunológias (CCDI)" da "Escola Paulista de Medicina". A eficiência da "Ficha Cadastral de Clientes"e do "Banco de Dados" informatizado foi evidenciada a partir da aplicação desses instrumentos a uma amostra de 50 clientes desse serviço. Caracterizamos o trabalho e o planejamento da Assistência de Enfermagem à população atendida pelo CCDI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.